Stonepine Capital Management, LLC

Stonepine Capital Management, LLC latest Q4_2020 13F filings reported $130,625,000 in market value on this 2021-02-12 report date . The portfolio quarterly return is 35.88%. This fund has 21 securities concentrations of 100% weights.

Stonepine Capital Management, LLC largest holding is Ligand Pharmaceuticals Incorporated with weight of 24.83% and $32,431,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-122020-12-31Q4_202013F-HR21$130,625,00035.88%
2020-11-132020-09-30Q3_202013F-HR17$96,131,00086.19%
2020-08-132020-06-30Q2_202013F-HR13$51,630,000-45.40%
2020-05-142020-03-31Q1_202013F-HR27$94,557,000-34.09%
2020-02-132019-12-31Q4_201913F-HR23$143,457,00039.24%
2019-11-132019-09-30Q3_201913F-HR26$103,032,000-29.06%
2019-08-132019-06-30Q2_201913F-HR25$145,241,000-16.46%
2019-05-142019-03-31Q1_201913F-HR30$173,855,00052.69%
2019-02-132018-12-31Q4_201813F-HR22$113,865,000-33.42%
2018-11-282018-09-30Q3_201813F-HR/A31$171,016,0000.00%
2018-11-132018-09-30Q3_201813F-HR31$159,157,000-3.29%
2018-08-142018-06-30Q2_201813F-HR25$164,570,000-11.82%
2018-05-142018-03-31Q1_201813F-HR30$186,623,00011.85%
2018-02-132017-12-31Q4_201713F-HR27$166,847,000-1.65%
2017-11-132017-09-30Q3_201713F-HR22$169,648,000-8.39%
2017-08-142017-06-30Q2_201713F-HR27$185,191,0004.36%
2017-05-122017-03-31Q1_201713F-HR21$177,452,0005.70%
2017-02-102016-12-31Q4_201613F-HR23$167,888,00036.91%
2016-11-142016-09-30Q3_201613F-HR17$122,629,00025.73%
2016-08-112016-06-30Q2_201613F-HR/A23$97,537,0000.00%
2016-08-102016-06-30Q2_201613F-HR23$97,537,00015.03%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
LIGAND PHARMACEUTICALS INCORPORATED CLASS 'B' COMMON STOCK USD0.001LGNDINCR$32,4310.06%24.83%$99.450.01%326,100
AMRYT PHARMA PLCAMYTINCR$20,0571.12%15.35%$14.160.85%1,416,483
DIAMEDICA THERAPEUTICS INCDMACINCR$9,6330.98%7.37%$10.14-0.17%950,000
AYTU BIOSCIENCE INCAYTUBUY$8,3650.00%6.40%$5.980.00%1,398,776
APOLLO ENDOSURGERY INCAPENINCR$7,9092.28%6.05%$3.400.63%2,326,165
CTI BIOPHARMA CORPCTICDECR$6,614-0.18%5.06%$3.22-0.45%2,054,000
IVERIC BIO INCISEEDECR$5,528-0.59%4.23%$6.91-0.66%800,000
XOMA CORP DELXOMAINCR$5,4780.94%4.19%$44.13-0.17%124,130
CATALYST BIOSCIENCES INCCBIODECR$5,265-0.13%4.03%$6.31-0.41%834,449
SCYNEXIS INCSCYXBUY$5,2400.00%4.01%$7.650.00%685,000
ADAMAS PHARMACEUTICALS INCADMSINCR$3,5010.29%2.68%$4.330.23%808,431
STRONGBRIDGE BIOPHARMA PLCSBBPDECR$3,281-0.19%2.51%$2.43-0.30%1,350,000
GAMIDA CELL LTDGMDABUY$3,1840.00%2.44%$8.390.00%379,470
CHIASMA INCCHMAINCR$3,1381.09%2.40%$4.351.06%721,307
NEOS THERAPEUTICS INCNEOSINCR$3,1000.33%2.37%$0.620.13%4,962,657
NOVUS THERAPEUTICS INCBUY$2,5770.00%1.97%$15.400.00%167,333
YUMANITY THERAPEUTICS INCYMTXBUY$1,8500.00%1.42%$17.000.00%108,847
AFFIMED N VAFMDINCR$1,2770.05%0.98%$5.82-0.39%219,340
VISTAGEN THERAPEUTICS INCVTGNBUY$9700.00%0.74%$1.940.00%500,000
APTEVO THERAPEUTICS INCAPVOBUY$6700.00%0.51%$36.650.00%18,280
CUMBERLAND PHARMACEUTICALS ICPIXDECR$557-0.71%0.43%$2.95-0.68%188,703
ANTARES PHARMA INCATRSSOLD$00.00%-100.00%$0.000.00%0
INTERPACE BIOSCIENCES INCIDXGSOLD$00.00%-100.00%$0.000.00%0
PROGENITY INCPROGSOLD$00.00%-100.00%$0.000.00%0